CLINICAL_TRIALS
trial_result
· 2012-10-26
Clinical Trial Update: Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence [Phase 2]
Summary
This update reports completion of a Phase 2 trial evaluating Behavioral Naltrexone Therapy as a treatment for heroin dependence (opioid use disorder).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Opiate Dependence | Phase 2 | Status: COMPLETED